Weill Cornell Medicine is committed to excellence in patient care, scientific discovery and the education of future physicians in New York City and around the world. Since 1898, our doctors and scientists have been engaged in world-class clinical care and cutting-edge research that connect patients to the latest treatment innovations and prevention strategies. Weill Cornell Medicine's powerful network of collaborators extends to its parent university Cornell University; to Qatar, where Weill Cornell Medicine-Qatar offers a Cornell University medical degree; and to programs in Tanzania, Haiti, Brazil, Austria and Turkey. Weill Cornell Medicine faculty provide comprehensive patient care at NewYork-Presbyterian/Weill Cornell Medical Center, NewYork-Presbyterian Lower Manhattan Hospital, NewYork-Presbyterian Queens and NewYork-Presbyterian Brooklyn Methodist Hospital. Weill Cornell Medicine is also affiliated with Houston Methodist.
Dr. Matthew Robbins, associate professor of neurology, received the 2020 National Headache Foundation Lectureship Award at the 33rd Annual Diamond Headache Clinic Research & Educational Foundation’s Conference. The foundation was established in 1987 to promote headache education among physicians and allied health professionals.
Dr. Anais Rameau, assistant professor of otolaryngology, has been selected for the prestigious French American Foundation Young Leaders Program. The foundation’s flagship program brings together a group of young leaders from a wide range of backgrounds, with the goal of forging bonds between France and the United States.
Dr. Roy M. Gulick, chief of the Division of Infectious Diseases, has been named co-chair of the NIH’s COVID-19 Treatment Guidelines. Working with two other co-chairs, Drs. Henry Masur ‘72 and H. Clifford Lane of the NIH, the guidelines will draw on the knowledge of a panel of experts and will be updated frequently with scientific evidence and data to inform clinicians on how to best manage patients with COVID-19.